Healthcare Dec 17, 2021 10:23 AM (GMT+8) · EqualOcean
On the 17th, yiouda health learned that recently, AI pharmaceutical start-up mindrank AI has completed a round of financing of tens of millions of dollars, which is jointly led by Huagai capital and Songhe capital, and the old shareholder Sherpa capital continues to increase its weight. This round of financing will support the company's team expansion, self-developed pipeline R & D and business expansion. Since the angel round of financing in May this year, wisdom Pharma will develop its own one-stop AI drug R & D platform molecule pro ™ It has successfully delivered the R & D milestone achievements of drug pipelines of several listed pharmaceutical enterprises and biotechnology companies, and signed further large pipeline orders. Meanwhile, wisdom Pharma has designed candidate molecules with the best potential of the same kind for a listed pharmaceutical enterprise partner, and has entered the follow-up preclinical development (ind enabling) stage.

This text is a result of machine translation.